NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)

Technical Analysis Report for USA stock ALNY Alnylam Pharmaceuticals. Dated: 03 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Opened at 321.37 and Closed at: 318.65, which is -2.01% of previous session's close. It moved within a range of 315.20 and 324.06
The session was a Bearish session with an average volume of 947600, which is -37.43% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.
• The stock has fallen, and its mid term trend is also negative and in a downtrend.
• Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Golden cross was found 3 days back on short term averages

Support for tomorrow is 312.5 and resistance for tomorrow is 321.36
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 314.55, 310.44 resistance for tomorrow's hourly charts is 323.41, 328.16

10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 330.57 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 327.6 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 357.9 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 402.99 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Alnylam Pharmaceuticals is 391.12 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Alnylam Pharmaceuticals is at 327.6 and 200 DMA is at 391.12, while 50 DMA and 100 DMA are at 357.9 and 402.99 respectively

Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 327.6 and 20 EMA is at 332.58

Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 357.9 and 50 EMA is at 355.88

Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 402.99 and 100 EMA is at 377.22

Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 391.12 and 200 EMA is at 373.17

Pfizer Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Pfizer Inc, about 8.71% more returns!

Penumbra Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Penumbra Inc, about 9.53% more returns!

Boston Scientific has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Boston Scientific, about 7.27% more returns!

Savara Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Savara Inc, about 13.56% more returns!

Staar Surgical has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Staar Surgical, about 17.33% more returns!

Radnet Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Radnet Inc, about 16.7% more returns!

Opko Health has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Opko Health, about 4.66% more returns!

Omeros Corporation has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Omeros Corporation, about 10.59% more returns!

Intellia Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 19.57% more returns!

Henry Schein has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Henry Schein, about 16.04% more returns!

Alnylam Pharmaceuticals has performed better than Genprex Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!

Dbv Technologies has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Dbv Technologies, about 2.88% more returns!

Champions Oncology has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Champions Oncology, about 0.65% more returns!

Alnylam Pharmaceuticals has performed better than Biomerica Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!

Alnylam Pharmaceuticals has performed better than Axsome Therapeutics in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!

Acadia Healthcare has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Acadia Healthcare, about 79.13% more returns!

Alnylam Pharmaceuticals Technical analysis of indicators

Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Alnylam Pharmaceuticals in short term but the buy signal is initial and weak.

Alnylam Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Alnylam Pharmaceuticals in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 330.99 and Alnylam Pharmaceuticals ALNY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.

Alnylam Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ALNY Experts View which covers a lot of information including buying and selling signals

ALNY future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet